Healthcare Innovations & Life Sciences Leadership with Suzy Engwall & David Reese | MedTech, Pharma, and MSO Growth

Host Roy Bejarano sits down with Suzy Engwall and David Reese to explore the intersection of MedTech, pharma, and healthcare services, focusing on how MSOs (Management Services Organizations) can play a larger role in healthcare innovation, clinical research, and early adoption of new medical technologies.

In this episode, Suzy and David discuss the commercialization of medical devices and pharmaceuticals, how healthcare providers can integrate life sciences into their business models, and whether MSOs should build their own GPOs and venture capital arms. They also address the challenges and opportunities in MedTech and pharma adoption for outpatient settings.

Timestamps:

• [00:01] Introduction to the podcast and guests, Suzy Engwall & David Reese
• [04:00] Why MSOs should take an active role in MedTech and Pharma innovation
• [12:00] Commercialization strategies: How medical devices and drugs enter the market
• [19:45] Private Equity vs. MSO-Owned GPOs: The business of healthcare innovation
• [26:30] The role of clinical research in MSO expansion and physician engagement
• [41:00] Venture Capital in Healthcare: Should MSOs fund life sciences innovations?
• [50:00] AI, Regulatory Trends, and the Future of MedTech & Pharma in Healthcare

Key Takeaways:

• MSOs Can Play a Larger Role in Healthcare Innovation: From GPOs to early adoption programs, outpatient providers should engage with MedTech and pharma earlier in the commercialization process.
• Building a Clinical Research Infrastructure is a Competitive Advantage: MSOs that develop in-house research capabilities can improve patient outcomes and attract top clinical talent.
• Healthcare Venture Capital is Growing: Health systems have led the way—now MSOs should explore funding innovation to support new medical technologies and revenue diversification.
• Regulatory & Technological Shifts Are Reshaping Healthcare: AI, cost pressures, and regulatory frameworks are changing how new treatments are developed and adopted.

Resources:

• Suzy Engwall: LinkedIn Profile linkedin.com/in/sengwall
• David Reese: https://www.scale-healthcare.com/employees/david-reese/
• Clinician Exchange: Website
• https://healthtechstrategies.com/
• https://alirahealth.com/

About the Guests:

Suzy Engwall is the CEO and Founder of HealthTech Strategies, LLC, a boutique consulting firm

She is a healthcare innovation leader, speaker, startup advisor and mentor that has been working to make change in healthcare for almost 2 decades.

David Reese is the Executive Partner, Infusion & Pharma Services at SCALE Healthcare

David is a seasoned and proven healthcare management professional whose career spans more than thirty years of experience in physician-office infusion services, new service-line start-ups, operational management, and business strategy and development settings.

David Reese, PhD Dr. Reese has a proven track record of leading and growing molecular diagnostics companies, raising funds, developing products, and building partnerships. He was the founder, CEO, and CSO of Provista Diagnostics, Inc., where he oversaw two CLIA/CAP laboratories and the commercialization of Videssa Breast, a novel blood-based test for breast cancer detection. He also served as the CEO and Lab Manager of Accurex Diagnostic Services, a COVID-19 and flu testing service provider, where he implemented the sales and marketing strategy and developed business development opportunities. Dr. Reese is passionate about advancing healthcare innovation and improving patient outcomes through his scientific and commercial expertise.

Healthcare, Healthcare Leadership, Healthcare Trends, Roy Bejarano, Healthcare Innovations, Healthcare Industry Insights, MedTech, Pharma, MSO Growth, Life Sciences, Clinical Research, Venture Capital in Healthcare, Suzy Engwall, David Reese, MedTech, pharma, healthcare services, MSOs,